Suppr超能文献

单胺与精神分裂症

Monoamines and schizophrenia.

作者信息

Sedvall G

机构信息

Department of Psychiatry and Psychology, Karolinska Institute, Stockholm, Sweden.

出版信息

Acta Psychiatr Scand Suppl. 1990;358:7-13. doi: 10.1111/j.1600-0447.1990.tb05279.x.

Abstract

The hypothesis that central biogenic amines may play a role in the pathophysiology of schizophrenia was originally based upon the fact that hallucinogenic and antipsychotic drugs have profound effects on central transmitter pathways where dopamine, noradrenaline and serotonin are involved. The structural similarities between hallucinogenic drugs such as amphetamine and mescaline, and catecholamines on the one hand and lysergic acid diethylamide (LSD) and indolamines such as serotonin on the other hand have by direct experimentation been shown to explain their important effects on the transmitter systems. The marked effect of several classes of chemically different antipsychotic drugs on central dopamine receptor function formed the basis for the dopamine hypothesis regarding the mechanisms of action of these drugs and also for the hypothesis that dopamine D2 receptor function played a significant role in the pathophysiology of schizophrenia. Direct experimental analysis of aminergic functions in the brain of schizophrenic patients, both during life and post mortem, has been and will for the foreseeable future continue to be a rational approach to the further elucidation of the validity of these hypotheses. Analysis of metabolite levels in the cerebrospinal fluid and plasma of schizophrenic patients has shown great variation in the results with reports of both elevated and reduced release of amines in the brains of schizophrenic patients. Analysis of the aminergic receptor structures in the postmortem human brain has relatively consistently revealed an increased density of D2 receptors in the major basal ganglia of schizophrenic patients. Whether these alterations represent a primary feature of brain structure in schizophrenia or a drug-induced effect still remains to be shown. Positron emission tomographic (PET) scan studies of D2 receptors in schizophrenia have demonstrated both increased densities and absence of change in the characteristics of D2 receptors in the patients as compared to matched controls.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

中枢生物胺可能在精神分裂症的病理生理学中起作用这一假说,最初是基于以下事实:致幻剂和抗精神病药物对涉及多巴胺、去甲肾上腺素和5-羟色胺的中枢递质途径有深远影响。一方面,苯丙胺和三甲氧苯乙胺等致幻剂与儿茶酚胺之间的结构相似性,另一方面,麦角酸二乙酰胺(LSD)和5-羟色胺等吲哚胺之间的结构相似性,已通过直接实验表明可解释它们对递质系统的重要影响。几类化学结构不同的抗精神病药物对中枢多巴胺受体功能的显著作用,构成了关于这些药物作用机制的多巴胺假说的基础,也构成了多巴胺D2受体功能在精神分裂症病理生理学中起重要作用这一假说的基础。对精神分裂症患者生前和死后大脑中胺能功能的直接实验分析,一直是且在可预见的未来仍将是进一步阐明这些假说有效性的合理方法。对精神分裂症患者脑脊液和血浆中代谢物水平的分析结果差异很大,有报告称精神分裂症患者大脑中胺的释放增加和减少。对死后人类大脑中胺能受体结构的分析相对一致地显示,精神分裂症患者主要基底神经节中D2受体密度增加。这些改变是精神分裂症大脑结构的主要特征还是药物诱导的效应,仍有待确定。与匹配的对照组相比,对精神分裂症患者D2受体的正电子发射断层扫描(PET)研究表明,患者中D2受体密度增加且其特征没有变化。(摘要截短为250字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验